AskBorsa

New Medical Centre Alexandria results, Q2 2026

Net profit, assets, equity and cash flow for Q2 2026, against the same period a year earlier, from the published financial statements.

Net profit10.9 millionEGP · −20.1% vs the same period a year earlier

In short

  • New Medical Centre Alexandria's net profit for Q2 2026 was about 10.9 million EGP, down −20.1% from 13.65 million EGP in Q2 2025.
Source: the Q2 2026 financial statements

Key lines against the same period a year earlier

This periodQ2 2025Change
Net profit10.9 million13.65 million−20.1%
Gross profit43.68 million39.57 million+10.4%
Total assets———
Total liabilities———
Shareholders' equity—243 million—
Total liabilities and equity460 million396 million+16.2%
Operating cash flow—-295 thousand—
Investing cash flow—-2.38 million—
Financing cash flow———
Net change in cash———

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.

Official report (PDF)All of New Medical Centre Alexandria's statements, five yearsAsk the AI analyst about AMES

New Medical Centre Alexandria's Q3 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for New Medical Centre Alexandria